Anticancer activities of sulindac in prostate cancer cells associated with c-Jun NH2-terminal kinase 1/β-catenin signaling

The non-steroidal anti-inflammatory agent, sulindac, has shown strong effects on cancer prevention in colorectal cancers, however, its anticancer activities on prostate cancer remain unclear. In the current study, human prostate cancer cell lines, LNCaP and PC-3, were treated with various concentrat...

Descripción completa

Detalles Bibliográficos
Autores principales: DU, JUN, GUO, YONGCHEN, BAO, YONGHUA, XING, MENGTAO, MAHMOUD, ABEER M., CHE, ZHENYONG, CHEN, ZHIGUO, YANG, WANCAI
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063579/
https://www.ncbi.nlm.nih.gov/pubmed/24959268
http://dx.doi.org/10.3892/ol.2014.2084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063579/
https://www.ncbi.nlm.nih.gov/pubmed/24959268
http://dx.doi.org/10.3892/ol.2014.2084

Ejemplares similares